Elevation in levels of SESN2 has been found in the mid brain of Parkinson’s patients (PD) while in-vitro neuroblastoma cells showed a protective role of SESN2 against 1-methyl-4-phenylpyridinium (MPP+) induced neurotoxicity23. Here, SESN2 is linked to Parkinsonism.